Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Michael A, Gaglia"'
Autor:
Michael J. Lipinski, Sarkis Kiramijyan, Michael A. Gaglia, Rebecca Torguson, Smita I. Negi, Jiaxiang Gai, Edward Koifman, Augusto D. Pichard, Ron Waksman, Romain Didier
Publikováno v:
The American Journal of Cardiology. 119:1324-1330
With steady growth in the use of drug-eluting stents (DES), the indications for bare metal stents (BMS) have significantly changed over the last decade. This study aims to describe trends in the use of BMS and the evolution of the population receivin
Autor:
Michael J. Lipinski, Michael A. Gaglia, Lowell F. Satler, Ron Waksman, Rebecca Torguson, Regina C. Lee, Augusto D. Pichard, Hector M. Garcia-Garcia
Publikováno v:
Cardiovascular Revascularization Medicine. 17:535-545
Background/purpose Numerous GPIs are available for PCI. Although they were tested in randomized controlled trials, a comparison between the different GPI strategies is lacking. Thus, we performed a Bayesian network meta-analysis to compare different
Autor:
Michael J. Lipinski, Nelson L. Bernardo, Lowell F. Satler, Robert Lager, Itsik Ben-Dor, Smita I. Negi, Edward Koifman, Michael A. Gaglia, William O. Suddath, Sarkis Kiramijyan, Rebecca Torguson, Nevin C. Baker, Robert Gallino, Ron Waksman, Jiaxiang Gai, Augusto D. Pichard, Ricardo O. Escarcega
Publikováno v:
Catheterization and Cardiovascular Interventions. 89:640-646
Objective Comparison of transradial versus transfemoral access for complex percutaneous coronary intervention (PCI) with regard to both complications and long-term outcomes. Background Radial access has been shown to confer superior results in patien
Autor:
Ricardo O. Escarcega, Sa'ar Minha, Itsik Ben-Dor, Romain Didier, Edward Koifman, Ron Waksman, Lowell F. Satler, Smita I. Negi, Rebecca Torguson, Sarkis Kiramijyan, Nevin C. Baker, Michael A. Gaglia, Marco A. Magalhaes, Zuyue Wang, Petros Okubagzi, Augusto D. Pichard, Gai Jiaxiang, Federico M. Asch
Publikováno v:
The American Journal of Cardiology. 117:1502-1510
The incidence of aortic regurgitation (AR) after transcatheter aortic valve replacement (TAVR) in a self-expanding and a balloon-expandable system is controversial. This study aimed to examine the incidence and severity of post-TAVR AR with the CoreV
Autor:
Jiaxing Gai, Michael A. Gaglia, Smita I. Negi, Romain Didier, Sarkis Kiramijyan, Augusto D. Pichard, Edward Koifman, Al Fazir Omar, Rebecca Torguson, Ron Waksman
Publikováno v:
American Heart Journal. 172:80-87
Cerebrovascular accident (CVA) and transient ischemic attack (TIA) related to percutaneous coronary intervention (PCI) are relatively rare complications, but they are associated with high morbidity and mortality. Given the evolution of both CVA risk
Autor:
Toby Rogers, William O. Suddath, Sarkis Kiramijyan, Smita I. Negi, Ron Waksman, Augusto D. Pichard, Arie Steinvil, Edward Koifman, Jiaxiang Gai, Rebecca Torguson, Michael J. Lipinski, Lowell F. Satler, Michael A. Gaglia
Publikováno v:
The American Journal of Cardiology. 117:526-531
Although metallic coronary stents significantly reduce angina pectoris compared with optimal medical therapy, angina after percutaneous coronary intervention (PCI) remains frequent. We, therefore, sought to compare the incidence of any angina during
Autor:
Hadiya A. Benn, Rebecca Torguson, Michael A. Gaglia, Ricardo O. Escarcega, Nevin C. Baker, Michael J. Lipinski, Ron Waksman
Publikováno v:
JACC: Cardiovascular Interventions. 9:12-24
Objectives The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) by cond
Autor:
Michael A. Gaglia
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 18(8)
Autor:
Michael A. Gaglia
Publikováno v:
Current Cardiovascular Risk Reports. 11
Antiplatelet therapy for patients undergoing percutaneous coronary intervention has rapidly evolved over the last 10 years, often outpacing clinical guidelines. This review appraises recent clinical trials within the context of landmark trials in int
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 20:144-156
Antiplatelet therapy is invariably prescribed for patients with peripheral arterial disease and critical limb ischemia, and numerous major society guidelines espouse their use, but high-quality data in this high-risk and challenging patient populatio